The linked FDA records link this applicant to two premarket notifications, both Traditional 510(k)s reviewed by the Radiology panel and not reviewed by a third party. One covers the Nuewa A20 family, the other the Resona I10 and Nuewa I10 families. Both list Shenzhen as the applicant city and carry a Summary statement. The records describe cleared device identities and filing scope; they do not establish sales, installed base or clinical performance. [1][2][4]
Nuewa A-series clearance, K261585
K261585 was received 13 May 2026 and decided 16 October 2026 as Substantially Equivalent. The device name lists Diagnostic Ultrasound System variants including Nuewa A20W, A20, A20 Exp, A20 Elite, A20Q, A MV, A Elite, A MS, A20 Premium, A20 Plus and A18. The record assigns product code IYN, regulation 892.1550, device class 2 and the classification name System, Imaging, Pulsed Doppler, Ultrasonic. [1][8]
An Innolitics record for the same clearance states that the diagnostic ultrasound system is comparable with and substantially equivalent to listed predicate devices, with Resona A10S named as the main predicate. That predicate statement is attributed to Innolitics, not to the FDA decision record itself. [8]
Resona and Nuewa I10-series clearance, K261617
K261617 was received 15 May 2026 and decided 8 October 2026 as Substantially Equivalent, Traditional type, not reviewed by a third party, with no combination product and no authorized Predetermined Change Control Plan. The device name lists Resona I10W, I10 Exp, I10, I10S, XI and I10 CV alongside Nuewa I10W, I10 Exp, I10, I10S and XI. [2][4]
The FDA database entry for K261617 lists subsequent product codes ITX and IYO in addition to IYN, and links a Summary document. A third-party index repeats the applicant, product code IYN, decision SESE, decision date and regulation number, and states it is not affiliated with or endorsed by the FDA. [4][5][6]
What the collection shows and does not show
The supplied portfolio contains two linked records, both on the 510(k) pathway, and both with decision code SESE; that is the full collection count as of the snapshot date. The smaller record sample also shows two SESE decisions, consistent with the full count rather than a separate measure. These figures describe supplied filings only, not total company clearances, sales or safety performance. [1][2]
A separate FDA record, K253049, names the same applicant with Resona A10S, A20 Pro, A20T, A20S, A20W, A20, A20 Exp, A20 Premium, A20 Elite, A20 Plus, A Elite, A MV, Eagus A20W and Eagus A20 diagnostic ultrasound systems. It is not part of the two-record collection and is cited only as an additional documented filing. [7]
Applicant identity and open questions
Both collection records name Shenzhen Mindray Bio-Medical Electronics Co., Ltd. as applicant, with a Shenzhen address and country code CN. That address is a filing address and does not establish a headquarters location. No parent, brand ownership, website, customer list or commercial availability is verified in the public documents. [1][2]

